【光大医药&海外】固生堂:业绩快速增长,名医“AI分身”值得期待

EBoversea
11 Apr

报告标题:《业绩快速增长,名医“AI分身”值得期待——固生堂(2273.HK)2024年报点评》报告发布日期:2025年4月9日分析师:王明瑞(执业证书编号:S0930520080004)分析师:吴佳青(执业证书编号:S0930519120001)往期回顾【光大医药&海外】歌礼制药-B:战略转型代谢性药物研发,减肥药数据表现优异【光大医药&海外】锦欣生殖:24年业绩符合预期,25年看好生育刺激政策...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10